Zejing Pharmaceutical is preparing for the registration of recombinant human thrombin and on-site verification of clinical trial data
Zejing Pharmaceutical stated on the interactive platform that the company maintains active communication with the Center for Drug Review and Inspection (CFDI) of the Food and Drug Administration and is actively preparing for the registration of recombinant human thrombin. Registration on-site verification and clinical trial data on-site verification. After donafenib was launched on the market, doctors gave good feedback and patients were taking the drug normally. The company also carried out a number of post-marketing studies. ( Science and Technology Innovation Board Daily)
For more hot information, insight analysis, research reports, live lectures... Please pay attention to [Hard Technology]
Welcome to search [Hard Technology] on all major platforms, and look for accounts with blue logos!
is here to see, understand and connect with hard technology! We focus on optoelectronic chips, artificial intelligence , aerospace, new energy, smart cars, biomedicine , science and technology finance and other industries, and rely on the unique scientific and technological intelligence data owned by the scientific and technological innovation intelligence SaaS service provider Smart Bud. Advantages, work with readers to see technology trends, understand hard technology industries, and connect to the innovative future. "Hard Technology" is produced by the Smart Bud Innovation Research Center.